Ethyl-4-Pyrazole Carboxylate

37622-90-5

Chenglian Pharmaceutical is an innovative high-tech pharmaceutica₽l enterprise that is market-oriented and realizes industrial development through ∞R&D innovation and technology transformation.

key word:

technology Pharmaceutical

Category:

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives to Ωbuild a large health industry finance platform company inte₹grating pharmaceutical, intelligent medical, bio pharmaceutical ∑R&D, industrial production and sales.

The chemical reactions involved in the existing products include Fouca'ult reaction, nitration reaction, sulfonation reaction, hydro≠genation reaction, fluorination reaction, chlorination reaction, brom£ination reaction, diazotization reaction, format reaction, etc.

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inhibitor ×developed by Merck. In October 2006, Sitagliptin phosp hate Januvia was approved by FDA as the first DPP4 inhibitor for the treat↔ment of type ⅱ diabetes mellitus. The characteristics ✘of this drug are that it can stimulate insulin secretion while re→ducing hunger without causing weight gain. Hypoglycemia and edema will not occur, and it is s uitable for diabetic patients with poor blood glucose control and frequent hypogπlycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech ph₹armaceutical enterprise that is market-oriented and realizes industrial development through R&D inΩnovation and technology transformation.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the most important products for☆ the treatment of arthritis. It is well tolerated and has a low inc₩idence of side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three major leukotrγiene receptor antagonists. In clinical application, it has good therapeutic₹ effect on atopic asthma and other types of bronchial asthma, and t¶he market prospect is huge. In the major category of asthma drugs, leu kotriene receptor antagonists have the fastest growing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is ma‌rket-oriented and realizes industrial development thr↔ough R&D innovation and technology transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the second drug approved by FDA​ for Alzheimer's disease in the United States. Its treatment reaches the target dose☆ and has low toxic and side effects. It has been widely recognized by our me✘dical community, and good tolerance is its biggest advantage. In October 19Ω99, Donepezil was launched in China under the trade name "Aricept", whi≈ch is the main chemical drug against Alzheimer's disease. At present, CFD£A has approved a number of domestic enterprises to produce donepez∑il preparations, the main dosage forms are tablets, capsules, disp↕ersive tablets, oral disintegrating tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (Eliquis, Bristol-Myers Sq uibb/Pfizer), a direct oral factor Xa inhibitor, was approved for use in₹ the 27 EU member states. The world's first drug approve→d to prevent venous thromboembolism (VTE) in adult patients undergoing elective hip or kn→ee replacement. From June 2019 to June 2020, the annual sales of apixaban produc↔ts overseas reached about $15.4 billion, with a year-on-year growth of nearly 32%, and th‌e API consumption reached about 23,960 kg, with a y★ear-on-year growth of about 28%. Compared with its main 'competitor, Rivaroxaban, the drug's annual overseas sales are about $4.5 billion high§er.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmace↑utical enterprise that is market-oriented and realizes industrial development through R&D innovatΩion and technology transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and manufactured by Genzyme. On December 2®9, 2004, it was approved by FDA for the treatment of refr'actory or relapsed acute lymphoblastic leukemia (ALL) in children.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical∑ enterprise that is market-oriented and realizes industrial dev∞elopment through R&D innovation and technology transformation.

Product Consulting

Our staff will contact you within 24 hours (working days). If you need other services, E-m★ail: 2880705932@qq.com